GW&K Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

GW&K Investment Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$48.7M	Sell	174,708 -2,375	-1%	-$684K	0.43%	78
2025 Q4	$53.7M	Sell	177,083 -6,762	-4%	-$2.11M	0.46%	73
2025 Q3	$51.5M	Buy	183,845 +36,632	+25%	+$9.97M	0.46%	71
2025 Q2	$35.5M	Buy	147,213 +3,334	+2%	+$788K	0.32%	125
2025 Q1	$35M	Sell	143,879 -1,565	-1%	-$471K	0.32%	124
2024 Q4	$47.8M	Buy	145,444 +212	+0.1%	+$72K	0.41%	89
2024 Q3	$48.6M	Buy	145,232 +4,391	+3%	+$1.39M	0.42%	89
2024 Q2	$38.5M	Buy	140,841 +2,955	+2%	+$859K	0.35%	113
2024 Q1	$47.7M	Buy	137,886 +93	+0.1%	+$30.6K	0.42%	94
2023 Q4	$44.5M	Sell	137,793 -6,921	-5%	-$2.17M	0.41%	93
2023 Q3	$51.9M	Sell	144,714 -205	-0.1%	-$79.1K	0.52%	69
2023 Q2	$54.9M	Buy	144,919 +24,946	+21%	+$10.2M	0.52%	67
2023 Q1	$57.5M	Buy	119,973 +1,727	+1%	+$808K	0.56%	63
2022 Q4	$49.7M	Buy	118,246 +32,940	+39%	+$13.3M	0.5%	75
2022 Q3	$35.6M	Buy	85,306 +12,447	+17%	+$6.21M	0.39%	110
2022 Q2	$36.1M	Sell	72,859 -8,852	-11%	-$4.61M	0.39%	111
2022 Q1	$46M	Sell	81,711 -24,026	-23%	-$14.5M	0.41%	106
2021 Q4	$79.9M	Sell	105,737 -13,012	-11%	-$9.74M	0.67%	39
2021 Q3	$88.6M	Sell	118,749 -1,194	-1%	-$894K	0.79%	22
2021 Q2	$77.3M	Buy	119,943 +1,820	+2%	+$1.11M	0.67%	32
2021 Q1	$67.5M	Buy	118,123 +26,568	+29%	+$15.7M	0.62%	37
2020 Q4	$53.4M	Buy	91,555 +38	+0%	+$21.6K	0.56%	43
2020 Q3	$47.2M	Sell	91,517 -5,422	-6%	-$2.75M	0.62%	38
2020 Q2	$43.8M	Sell	96,939 -2,531	-3%	-$1.12M	0.61%	45
2020 Q1	$34.9M	Buy	99,470 +5,721	+6%	+$2.1M	0.61%	45
2019 Q4	$34.7M	Sell	93,749 -3,173	-3%	-$1.12M	0.46%	78
2019 Q3	$32.3M	Buy	96,922 +9,696	+11%	+$3.16M	0.45%	86
2019 Q2	$27.3M	Sell	87,226 -1,718	-2%	-$514K	0.41%	93
2019 Q1	$27.2M	Buy	88,944 +21,395	+32%	+$5.77M	0.44%	93
2018 Q4	$15.7M	Buy	67,549 +806	+1%	+$216K	0.31%	143
2018 Q3	$20.9M	Buy	+66,743	New	+$20.7M	0.34%	137